These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 32508524)
1. Long-Term Outcomes of Behçet's Syndrome-Related Uveitis: A Monocentric Italian Experience. Sota J; Cantarini L; Vitale A; Sgheri A; Gentileschi S; Caggiano V; Gelardi V; Frediani B; Tosi GM; Fabiani C Mediators Inflamm; 2020; 2020():6872402. PubMed ID: 32508524 [TBL] [Abstract][Full Text] [Related]
2. [Efficacy of TNF-alpha antagonist and other immunomodulators in the treatment of patients with ophthalmologic manifestations of Behcet's disease and HLA B51 positive vasculitis]. Zlatanović G; Jovanović S; Veselinović D; Zivković M Vojnosanit Pregl; 2012 Feb; 69(2):168-74. PubMed ID: 22500372 [TBL] [Abstract][Full Text] [Related]
3. Pattern and causes of visual loss in Behçet's uveitis: short-term and long-term outcomes. Amer R; Alsughayyar W; Almeida D Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1423-1432. PubMed ID: 28396946 [TBL] [Abstract][Full Text] [Related]
4. Pattern of uveitis in Behçet's disease in a referral center in Tunisia, North Africa. Khairallah M; Attia S; Yahia SB; Jenzeri S; Ghrissi R; Jelliti B; Zaouali S; Messaoud R Int Ophthalmol; 2009 Jun; 29(3):135-41. PubMed ID: 18365145 [TBL] [Abstract][Full Text] [Related]
5. Pattern and Visual Prognostic Factors of Behcet's Uveitis in Northwest Iran. Alizadeh Ghavidel L; Bagheri M; Mousavi F; Rezaei L; Hazeri S; Hashemi HS J Ophthalmic Vis Res; 2022; 17(2):242-251. PubMed ID: 35765637 [TBL] [Abstract][Full Text] [Related]
6. Uveitis in Behçet disease in a tertiary center over 25 years: the KKESH Uveitis Survey Study Group. Arevalo JF; Lasave AF; Al Jindan MY; Al Sabaani NA; Al-Mahmood AM; Al-Zahrani YA; Al Dhibi HA; ; Am J Ophthalmol; 2015 Jan; 159(1):177-84.e1-2. PubMed ID: 25448998 [TBL] [Abstract][Full Text] [Related]
7. Successful Remission with Upadacitinib in Two Patients with Anti-TNF-Refractory Macular Edema Associated with Behçet's Uveitis. Tao T; He D; Peng X; Huang Z; Su W Ocul Immunol Inflamm; 2024 Oct; 32(8):1897-1900. PubMed ID: 37801670 [TBL] [Abstract][Full Text] [Related]
8. Spectrum of Behçet's disease in the Indian population. Sachdev N; Kapali N; Singh R; Gupta V; Gupta A Int Ophthalmol; 2009 Dec; 29(6):495-501. PubMed ID: 18936879 [TBL] [Abstract][Full Text] [Related]
9. Uveitis in Behçet disease: an analysis of 880 patients. Tugal-Tutkun I; Onal S; Altan-Yaycioglu R; Huseyin Altunbas H; Urgancioglu M Am J Ophthalmol; 2004 Sep; 138(3):373-80. PubMed ID: 15364218 [TBL] [Abstract][Full Text] [Related]
10. [Clinical features of patients with Behcet's uveitis]. Liu XS; Gao F; Zhao C; Zhang MF Zhonghua Yan Ke Za Zhi; 2020 Mar; 56(3):217-223. PubMed ID: 32187951 [No Abstract] [Full Text] [Related]
11. Ocular Manifestations, Conventional Fundus Fluorescein Angiographic Findings, and Relationship Between Angiographic Findings and Visual Acuity in Behçet's Disease. Bazvand F; Zarei M; Ebrahimiadib N; Karkhaneh R; Davoudi S; Soleimanzadeh M; Sharifian E; Roohipoor R; Modjtahedi BS Semin Ophthalmol; 2017; 32(6):764-771. PubMed ID: 27715380 [TBL] [Abstract][Full Text] [Related]
12. Intravitreal Dexamethasone Implant as an Adjunct Weapon for Severe and Refractory Uveitis in Behçet's Disease. Fabiani C; Emmi G; Lopalco G; Vannozzi L; Bacherini D; Guerriero S; Franceschini R; Frediani B; Iannone F; Marco Tosi G; Rigante D; Cantarini L Isr Med Assoc J; 2017 Jul; 19(7):415-419. PubMed ID: 28786255 [TBL] [Abstract][Full Text] [Related]
13. [Association between optical coherence tomography findings and visual acuity of Behcet's disease-associated uveitis patients during remission stage]. Zhou W; Yang Z; Liu X; Han X; Zhang M Zhonghua Yan Ke Za Zhi; 2015 Oct; 51(10):746-9. PubMed ID: 26693769 [TBL] [Abstract][Full Text] [Related]
14. Clinical features of chinese patients with Behçet's disease. Yang P; Fang W; Meng Q; Ren Y; Xing L; Kijlstra A Ophthalmology; 2008 Feb; 115(2):312-318.e4. PubMed ID: 17692378 [TBL] [Abstract][Full Text] [Related]
15. Ocular Manifestations and Visual Outcomes of Behçet's Uveitis in a Thai population. Pathanapitoon K; Kunavisarut P; Saravuttikul FA; Rothova A Ocul Immunol Inflamm; 2019; 27(1):2-6. PubMed ID: 29020486 [TBL] [Abstract][Full Text] [Related]
16. TWENTY-FOUR MONTH FOLLOW-UP OF TOCILIZUMAB THERAPY FOR REFRACTORY UVEITIS-RELATED MACULAR EDEMA. Mesquida M; Molins B; Llorenç V; Hernández MV; Espinosa G; Sainz de la Maza M; Adán A Retina; 2018 Jul; 38(7):1361-1370. PubMed ID: 28520640 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema. Bae JH; Lee CS; Lee SC Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170 [TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes of small-incision cataract surgery in patients with uveitis. Bhargava R; Pandey K; Mehta B Indian J Ophthalmol; 2022 Nov; 70(11):3927-3932. PubMed ID: 36308129 [TBL] [Abstract][Full Text] [Related]
19. Visual outcome in ocular sarcoidosis: retrospective evaluation of risk factors. Miserocchi E; Modorati G; Di Matteo F; Galli L; Rama P; Bandello F Eur J Ophthalmol; 2011; 21(6):802-10. PubMed ID: 21374555 [TBL] [Abstract][Full Text] [Related]
20. Intravitreal triamcinolone acetonide in the management of cystoid macular edema in Behçet's disease. Atmaca LS; Yalçindağ FN; Ozdemir O Graefes Arch Clin Exp Ophthalmol; 2007 Mar; 245(3):451-6. PubMed ID: 17226025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]